Filter
304
Text search:
mRNA
Featured
Recommendations
56
New Publications
8
Language
Document type
Guidelines
99
Fact sheets
64
Studies & Reports
38
No document type
32
Videos
29
Manuals
11
Resource Platforms
11
Strategic & Response Plan
8
Training Material
5
Infographics
3
Situation Updates
2
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
16
Russia
12
Global
10
Ukraine
8
Middle East and North Africa
7
Latin America and the Carribbean
7
India
6
Nigeria
4
Syria
4
Ecuador
4
Yemen
4
Lebanon
3
Mozambique
3
Argentina
3
Eastern Europe
3
Senegal
2
Mali
2
Uganda
2
Niger
2
Haiti
2
Somalia
2
South Sudan
2
China
2
South Africa
2
Sudan
2
Peru
2
Chile
2
Western and Central Europe
2
Africa
2
Kazakhstan
2
Belarus
2
Burkina Faso
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Ethiopia
1
Cameroon
1
Iraq
1
Jordan
1
Egypt
1
Chad
1
Kenya
1
Rwanda
1
Indonesia
1
Mauritania
1
Benin
1
Dominican Republic
1
Cuba
1
Colombia
1
Honduras
1
El Salvador
1
Bolivia
1
Libya
1
Angola
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
Venezuela
1
Congo-Brazzaville
1
Qatar
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
15
Public Health
8
Key Resources
8
Pharmacy & Technologies
4
Women & Child Health
3
Capacity Building
1
Toolboxes
COVID-19
198
Refugee
22
TB
9
HIV
6
Mental Health
5
Ebola
4
Conflict
4
Rapid Response
4
Pharmacy
3
NTDs
3
Health Financing Toolbox
3
NCDs
2
Zika
1
Specific Hazards
1
Global Health Education
1
AMR
1
Planetary Health
1
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co
...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the
...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in the capacities of countries at all levels of develop
...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th
...
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not
...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit
...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh
...
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID
...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr
...
A erradicação da varíola humana (mpox em inglês) foi certificada em 1980. A varíola símia (mpox em inglês) é endêmica nos países da África Central e Ocidental desde a sua primeira detecção, em 1958. Trata-se de uma zoonose cujos casos geralmente ocorrem perto de florestas tropicais, ond
...
